BCM
PRAH

Bridgeway Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bridgeway Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,100
Closed -$423K – 1470
2018
Q1 		$423K Sell
5,100
-3,100
-38% -$275K ﹤0.01% 1137
2017
Q4 		$747K Sell
8,200
-900
-10% -$74.9K 0.01% 957
2017
Q3 		$693K Hold
9,100
– – 0.01% 983
2017
Q2 		$683K Buy
+9,100
New +$631K 0.01% 976

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's PRAH Position: Q2 2018 in Review

Bridgeway Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2018, closing a stake of 5,100 shares — an estimated $423K sold.

Bridgeway Capital Management first reported a position in PRAH in Q2 2017 and held it in 4 quarters. The position peaked at $747K in Q4 2017. 300 funds tracked by Wall St. Rank hold PRAH as of Q2 2018.

  • Bridgeway Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bridgeway Capital Management sold 5,100 PRA Health Sciences, Inc. shares in Q2 2018, an estimated $423K.
  • Bridgeway Capital Management first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 4 quarters.
  • Bridgeway Capital Management's PRA Health Sciences, Inc. position peaked at $747K in Q4 2017.
  • 300 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2018.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.